Social media support groups may ease loneliness in fibromyalgia

NCT ID NCT07715877

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study looks at whether joining a private social media group with others who have fibromyalgia can improve feelings of loneliness, hopelessness, and overall well-being. Researchers analyzed data from over 1,000 adults with fibromyalgia who participated in an online support community. The goal is to see if connecting with others who share similar struggles can lead to better mental and physical health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
social media support group
What this could lead to
If it works, this could point toward a low-cost, scalable way to reduce loneliness and hopelessness in people with fibromyalgia.
What could go wrong
This is an observational analysis of existing data, not a controlled experiment, so it cannot prove cause and effect. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,041 people

The number who actually took part.

Started

Jan 2023

Finished

Oct 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study participants were adults who can regularly access/use social media, who were recruited via online advertisements.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years of age or older * Can read and write English proficiently * Live in the USA * Carry a diagnosis of fibromyalgia Exclusion Criteria: * Younger than 18-years-old * Cannot read or write English proficiently * Does not live in the U.S. * Does not carry fibromyalgia diagnosis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fibromyalgia (FM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression fibromyalgia Suicidal Ideation Suicide

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Albert Einstein College of Medicine

    The Bronx, New York, 10461, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.